MedPath

Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy

Phase 3
Completed
Conditions
Cystic Fibrosis
Interventions
Registration Number
NCT04058366
Lead Sponsor
Vertex Pharmaceuticals Incorporated
Brief Summary

This study evaluated the long-term safety, efficacy, and pharmacodynamics of elexacaftor (ELX, VX-445) in triple combination (TC) with tezacaftor (TEZ) and ivacaftor (IVA) in subjects with cystic fibrosis (CF) who are heterozygous for the F508del mutation and a gating or residual function mutation (F/G and F/RF genotypes).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
251
Inclusion Criteria
  • Completed study drug treatment in parent study (VX18-445-104); or had study drug interruption(s) in parent study but completed study visits up to the last scheduled visit of the Treatment Period in the parent study

Key

Exclusion Criteria
  • History of study drug intolerance in parent study

Other protocol defined Inclusion/Exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ELX/TEZ/IVAELX/TEZ/IVAPart A: Participants received ELX (elexacaftor) 200 milligram (mg) once daily (qd)/TEZ 100 mg qd/IVA 150 mg every 12 hours (q12h) in the treatment period for 96 weeks. Part B: Participants from certain countries participated in Part B and continued to receive ELX 200 mg qd /TEZ 100 mg qd/IVA 150 mg q12h in the treatment period for 48 weeks.
ELX/TEZ/IVAIVAPart A: Participants received ELX (elexacaftor) 200 milligram (mg) once daily (qd)/TEZ 100 mg qd/IVA 150 mg every 12 hours (q12h) in the treatment period for 96 weeks. Part B: Participants from certain countries participated in Part B and continued to receive ELX 200 mg qd /TEZ 100 mg qd/IVA 150 mg q12h in the treatment period for 48 weeks.
Primary Outcome Measures
NameTimeMethod
Part A: Safety and Tolerability as Assessed by Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)From Baseline up to Week 100
Secondary Outcome Measures
NameTimeMethod
Part A: Absolute Change From Parent Study Baseline in Cystic Fibrosis Questionnaire-Revised (CFQ-R) Respiratory Domain ScoreFrom Baseline at Week 96

The CFQ-R is a validated participant-reported outcome measuring health-related quality of life for participants with cystic fibrosis. Respiratory domain assessed respiratory symptoms, score range: 0-100; higher scores indicating fewer symptoms and better health-related quality of life.

Part A: Absolute Change From Parent Study Baseline in Sweat Chloride (SwCl)From Baseline at Week 96

Sweat samples were collected using an approved collection device.

Part A: Absolute Change From Parent Study Baseline in Body Mass Index (BMI)From Baseline at Week 96

BMI was defined as weight in kilogram (kg) divided by height in square meter (m\^2).

Part A: Absolute Change From Parent Study Baseline in BMI Z-scoreFrom Baseline at Week 96

BMI was defined as weight in kilogram (kg) divided by squared height in meters (m\^2). The z-score is a statistical measure to describe whether a value was above or below the standard. A z-score of 0 is equal to the standard. Lower numbers indicate values lower than the standard and higher numbers indicate values higher than the standard.

Part A: Absolute Change From Parent Study Baseline in Body WeightFrom Baseline at Week 96
Part A: Absolute Change From Parent Study Baseline in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1)From Baseline at Week 96

FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration.

Trial Locations

Locations (84)

Children's Hospital of Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center

🇺🇸

Cleveland, Ohio, United States

Indiana University

🇺🇸

Indianapolis, Indiana, United States

University of Washington Medical Center

🇺🇸

Seattle, Washington, United States

The University of Texas Southwestern Medical Center

🇺🇸

Dallas, Texas, United States

University Hospital Limerick (Adults)

🇮🇪

Limerick, Ireland

University of North Carolina Hospitals

🇺🇸

Chapel Hill, North Carolina, United States

Children's Health Ireland at Crumlin

🇮🇪

Dublin, Ireland

St. Vincent's University Hospital

🇮🇪

Dublin, Ireland

Mount Sinai Beth Israel

🇺🇸

New York, New York, United States

Centre Hospitalier Lyon Sud

🇫🇷

Benite Cedex, France

University of Miami Miller School of Medicine

🇺🇸

Miami, Florida, United States

Justus-Liebig-Universitaet Gießen Zentrum fur Kinderheilkunde und Jugendmedizin

🇩🇪

Giessen, Germany

The Prince Charles Hospital

🇦🇺

Chermside, Australia

Universitätsklinikum Halle (Saale) / Universitätsklinik und Poliklinik für Innere Medizin, Schwerpunkt Pneumologie

🇩🇪

Halle, Germany

St. Paul's Hospital

🇨🇦

Vancouver, Canada

Telethon Kids Institute

🇦🇺

Nedlands, Australia

Banner University of Arizona Medical Center

🇺🇸

Tucson, Arizona, United States

Washington University School of Medicine / St. Louis Children's Hospital

🇺🇸

Saint Louis, Missouri, United States

Boston Children's Hospital

🇺🇸

Boston, Massachusetts, United States

UC Health Holmes

🇺🇸

Cincinnati, Ohio, United States

Central Florida Pulmonary Group, PA

🇺🇸

Orlando, Florida, United States

Texas Children's Hospital

🇺🇸

Houston, Texas, United States

Dell Children's Medical Group

🇺🇸

Austin, Texas, United States

CHU de Montpellier - Hopital Arnaud de Villeneuve

🇫🇷

Montpellier Cedex 5, France

The Royal Children's Hospital

🇦🇺

Parkville, Australia

Hopital Necker, Enfants Malades

🇫🇷

Paris Cedex 15, France

University of Wisconsin Hospital and Clinics

🇺🇸

Madison, Wisconsin, United States

Alfred Hospital

🇦🇺

Melbourne, Australia

Queensland Children's Hospital

🇦🇺

South Brisbane, Australia

Nationwide Children's Hospital

🇺🇸

Columbus, Ohio, United States

Beaumont Hospital

🇮🇪

Dublin, Ireland

Groupe Hospitaler Pellegrin, CHU De Bordeaux

🇫🇷

Bordeaux cedex, France

Azienda Ospedaliero Universitaria Ospedale Riuniti

🇮🇹

Ancona, Italy

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

🇮🇹

Milano, Italy

Hospital Universitario y Politecnico La Fe

🇪🇸

Valencia, Spain

Hospital Virgen de la Arrixaca

🇪🇸

Murcia, Spain

Liverpool Heart and Chest Hospital

🇬🇧

Liverpool, United Kingdom

Royal Brompton & Harefield NHS Foundation Trust, Royal Brompton Hospital

🇬🇧

London, United Kingdom

Charite Paediatric Pulmonology Department

🇩🇪

Berlin, Germany

Ruhrlandklinik Westdeutsches Lungenzentrum am Klinikum Essen

🇩🇪

Essen, Germany

CHU Marseille - Hopital Nord

🇫🇷

Marseille, France

Pneumologisches Studienzentrum Muenchen-West

🇩🇪

Muenchen, Germany

University Hospital Wuerzburg

🇩🇪

Würzburg, Germany

IRCCS Istituto Giannina Gaslini-Ospedale Pediatrico

🇮🇹

Genova, Italy

Royal Devon and Exeter NHS Foundation Trust, Royal Devon and Exeter Hospital

🇬🇧

Exeter, United Kingdom

Academic Medical Center

🇳🇱

Amsterdam, Netherlands

St. James University Hospital

🇬🇧

Leeds, United Kingdom

Hospital Universitario Virgen del Rocio

🇪🇸

Sevilla, Spain

Juliane Marie Center, Rigshospitalet

🇩🇰

Copenhagen, Denmark

McGill University Health Center

🇨🇦

Montréal, Canada

Clinical Research Facility, Queen Elizabeth University Hospital

🇬🇧

Glasgow, United Kingdom

Wythenshawe Hospital

🇬🇧

Manchester, United Kingdom

Hopital Pontchaillou CHU de Rennes

🇫🇷

Rennes Cedex, France

Stanford University

🇺🇸

Palo Alto, California, United States

Miller Children's Hospital / Long Beach Memorial

🇺🇸

Long Beach, California, United States

Massachusetts General Hospital Cystic Fibrosis Center Clinical Rsearch Center

🇺🇸

Boston, Massachusetts, United States

Columbia University Medical Center

🇺🇸

New York, New York, United States

Children's Hospital of Pittsburgh of UPMC

🇺🇸

Pittsburgh, Pennsylvania, United States

Westmead Hospital

🇦🇺

Westmead, Australia

Universitair Ziekenhuis Gent

🇧🇪

Gent, Belgium

Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg

🇧🇪

Leuven, Belgium

CHRU de Lille - Hopital Albert Calmette

🇫🇷

Lille, France

Ospedale Pediatrico Bambino Gesu

🇮🇹

Rome, Italy

Azienda Ospedaliera di Verona-Ospedale Civile Maggiore

🇮🇹

Verona, Italy

University Medical Center, Utrecht, Department of Pulmonology and Tuberculosis

🇳🇱

Heidelberglaan, Netherlands

Papworth Hospital NHS Foundation Trust, Papworth Everard

🇬🇧

Cambridge, United Kingdom

Hospital Universitari Vall d´Hebron Servicio de Broncoscopia

🇪🇸

Barcelona, Spain

Southampton General Hospital

🇬🇧

Southampton, United Kingdom

Mater Adult Hospital

🇦🇺

South Brisbane, Australia

ProMedica Toledo Hospital/Toledo Children's Hospital/Pediatric Pulmonary & Cystic Fibrosis Center

🇺🇸

Toledo, Ohio, United States

Hopital Cochin

🇫🇷

Paris, France

National Jewish Health

🇺🇸

Denver, Colorado, United States

University of California Davis Medical Center

🇺🇸

Sacramento, California, United States

University of California San Francisco, Lung Transplant Program

🇺🇸

San Francisco, California, United States

Oregon Health & Science University

🇺🇸

Portland, Oregon, United States

Michigan Medicine

🇺🇸

Ann Arbor, Michigan, United States

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

University of Oklahoma Health Sciences Center

🇺🇸

Oklahoma City, Oklahoma, United States

University of Utah / Primary Children's Medical Center

🇺🇸

Salt Lake City, Utah, United States

Cliniques Universitaires de Bruxelles Hopital Erasme

🇧🇪

Brussels, Belgium

Universitair Ziekenhuis Brussel - Campus Jette

🇧🇪

Brussels, Belgium

University of Kentucky

🇺🇸

Lexington, Kentucky, United States

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath